Taro Pharmaceutical Industries Ltd (NYSE:TARO)

76.08
Delayed Data
As of Oct 11
 +1.63 / +2.19%
Today’s Change
72.97
Today|||52-Week Range
109.42
-10.11%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2016

2017

2018

2019
Revenue and IncomeNet Revenues950.8M879.4M661.9M669.9M
 
 
 
 
 
Cost of Goods Sold154.9M193.0M181.9M205.6M
 
 
 
 
 
Depreciation And Amortization14.8M14.8M16.5M18.6M
 
 
 
 
 
 
Operating ExpensesGross Income781.0M671.5M463.5M445.7M
 
 
 
 
 
General Expenses163.5M156.3M158.6M153.2M
 
 
 
 
 
Research And Development71.2M70.6M70.4M63.2M
 
 
 
 
 
Total Operating Expenses333.3M364.2M357.0M377.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income617.5M515.2M304.9M292.5M
 
 
 
 
 
Extraordinary Credit0.000.000.003.7M
 
 
Extraordinary Charge-3.0M-276.0K-1.9M--
 
 
 
 
Interest Expense On Debt473.0K0.000.007.9M
 
 
 
Other Expenses9.7M31.2M-30.9M26.9M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income636.8M560.8M292.4M356.9M
 
 
 
 
 
Income Taxes-95.3M-103.8M-82.0M-74.7M
 
 
 
 
 
Minority Interest-339.0K-310.0K-1.1M-345.0K
 
 
 
 
 
Discontinued Operations-236.0K-352.0K-335.0K0.00
 
 
 
 
Net Income540.9M456.4M211.2M281.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS----40.2M39.0M
 
 
 
Shares To Calculate EPS Diluted----40.2M39.0M
 
 
 
 
Earnings Per ShareEPS$12.62$11.05$5.26$7.23
 
 
 
 
 
EPS Diluted----$5.26$7.23